Maintained by Sreepriya Prasannan

MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist

Compiled from ClinicalTrials.gov and CTIS registry records · Last verified 27 Sep 2026 · Editorial standards

At a glance

Peking University Third Hospital is the lead sponsor of 159 current clinical trials in our China register. 86 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Metformin, Cisplatin and Enfortumab Vedotin. The most-studied condition is Olfactory Dysfunction.

ClinicalTrials.gov trials by status

Recruiting8654%
Not yet open5132%
Active, closed96%
By invitation138%

Trials by phase

Not applicable7648%
Observational6943%
Phase 264%
Phase 464%
Phase 1/211%
Phase EARLY_PHASE111%

Clinical trials sponsored by Peking University Third Hospital

159 on ClinicalTrials.gov

Study	Phase	Status	Start	Registers
Comparison of MBR + Suture Tape, MBR, and Anatomic Reconstruction for CLAI in GJL Cases: A Prospective Cohort Study NCT05698446 · ClinicalTrials.gov ↗ · Ankle Sprains, Hypermobility Syndrome	Observational	Recruiting	2021-11	China
Prospective Cohort Study on Refractory Rheumatoid Arthritis NCT07126431 · ClinicalTrials.gov ↗ · Rheumatoid Arthritis	Observational	Recruiting	2023-01	China
Exploring the Value of 18F-AlF-FAPI PET/CT in Assessing the Activity of Thyroid Eye Disease NCT06359795 · ClinicalTrials.gov ↗ · Thyroid Eye Disease	Not applicable	Recruiting	2023-12	China
Evaluation of Long-term Isokinetic Training of Knee Joint NCT06674473 · ClinicalTrials.gov ↗ · Knee Injuries and Disorders	Not applicable	Recruiting	2024-11	China
PD-1 Antibody Carilizumab Combined with Apatinib for Unresectable Stage III and IV DMMR Gastric Cancer NCT06792162 · ClinicalTrials.gov ↗ · Gastric Cancer	Phase 2	Recruiting	2023-04	China
Treatment of Oral Lichen Planus With Paeoniflorin and Photodynamic Therapy NCT05973097 · ClinicalTrials.gov ↗ · Oral Lichen Planus	Not applicable	Recruiting	2023-07	China
Glofitamab Combined With Lenalidomide in High Risk Patients With Relapsed or Refractory Mantle Cell Lymphoma NCT07460362 · ClinicalTrials.gov ↗ · MCL, Relapsed or Refractory Mantle Cell Lymphoma (MCL) Drugs: Glofitamab, Lenalidomide	Phase 2	Recruiting	2025-08	China
Clinical Cohort Study in Patients With Different Subtypes of Primary Sjogren Syndrome Related Dry Eye NCT05605314 · ClinicalTrials.gov ↗ · Dry Eye	Observational	Recruiting	2021-01	China
Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases NCT06828042 · ClinicalTrials.gov ↗ · Systemic Lupus Erthematosus, Systemic Sclerosis (SSc), Sjogren Syndrome	Phase 1/2	Recruiting	2025-07	China
Pomalidomide Plus Orelabrutinib and Zuberitamab in Untreated Mantle Cell Lymphoma NCT07257510 · ClinicalTrials.gov ↗ · Mantle Cell Lymphoma (MCL), POZ Drugs: Orelabrutinib, Pomalidomide, Zuberitamab	Not applicable	Recruiting	2025-08	China
Evaluating the Usefulness of 18F-AlF-FAPI PET/ CT in Orbital Neoplasms NCT06791226 · ClinicalTrials.gov ↗ · Orbital Neoplasms	Not applicable	Recruiting	2024-07	China
Safety and Effectiveness Evaluation of Spinal Laminectomy Robot NCT06593574 · ClinicalTrials.gov ↗ · Lumbar Spinal Stenosis, Lumbar Disc Herniation	Not applicable	Recruiting	2024-10	China
Efficacy and Safety of Photodynamic Therapy for Cervical and Vaginal Intraepithelial Neoplasia NCT06982976 · ClinicalTrials.gov ↗ · Precancerous Cervical Lesion	Not applicable	Recruiting	2025-02	China
Evaluating the Efficacy and Safety of Teprotumumab N01 in Patients With Thyroid Eye Disease. NCT07423013 · ClinicalTrials.gov ↗ · Thyroid Eye Disease	Not applicable	Recruiting	2025-11	China
A Study of Maintenance DCVAC/OvCa After First-line Chemotherapy Added Standard of Care NCT04834544 · ClinicalTrials.gov ↗ · Epithelial Ovarian Carcinoma, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma	Phase 2	Recruiting	2021-04	China
Development and Validation of an Ovarian Cancer Risk Prediction Model for Family Members of Ovarian Cancer Probands NCT07039552 · ClinicalTrials.gov ↗ · Hereditary Breast and Ovarian Cancer Syndrome, BRCA Mutations	Observational	Recruiting	2016-01	China
Randomized Controlled Trial on the Efficacy and Safety of Xiang Lei Ointment in Diabetic-related Ulcer Management NCT06841237 · ClinicalTrials.gov ↗ · Diabetic Wound, Wound Infection, Wound Heal	Not applicable	Recruiting	2025-04	China
Adenomyosis Patients With Infertility and Immunological Factors NCT06123975 · ClinicalTrials.gov ↗ · Adenomyosis	Observational	Recruiting	2024-03	China
EV + Toripalimab vs GC as Neoadjuvant Therapy in Locally Advanced/High-Risk MIBC NCT07647289 · ClinicalTrials.gov ↗ · Muscle-Invasive Bladder Cancer (MIBC) Drugs: Cisplatin, Enfortumab Vedotin, Gemcitabine	Phase 2	Recruiting	2025-04	China
A Study to Test Tetrandrine Tablets for Connective Tissue Disease-Related Lung Disease NCT07319598 · ClinicalTrials.gov ↗ · Interstitial Lung Disease (ILD), Connective Tissue Disease-associated Interstitial Lung Disease	Phase 4	Recruiting	2023-11	China
Comparison of MBR + Suture Tape and MBR for CLAI : A Prospective Cohort Study NCT06897293 · ClinicalTrials.gov ↗ · Ankle Sprain, Hypermobility, Joint	Observational	Recruiting	2021-06	China
Surgical Treatment of Irreducible Atlantoaxial Dislocation NCT05847270 · ClinicalTrials.gov ↗ · Irreducible Atlantoaxial Dislocation	Not applicable	Recruiting	2023-07	China
Application of a Wearable Device-Based Intelligent Rehabilitation System in the Rehabilitation of Patients With Frozen Shoulder NCT07422714 · ClinicalTrials.gov ↗ · Range of Motion, Articular	Not applicable	Recruiting	2026-01	China
Multisensor Wireless Pressure Microcatheter For Microvascular Function Assessment In ANOCA/INOCA Patients: A Prospective, Multicenter, Single-Group Target Value Study NCT07453381 · ClinicalTrials.gov ↗ · Coronary Microvascular Dysfunction (CMD)	Observational	Recruiting	2026-06	China
Validation of RCC Predicting Model With Emulated-target Trial NCT07117227 · ClinicalTrials.gov ↗ · Renal Cell Carcinoma (Kidney Cancer), Renal Cell Carcinoma (RCC), Tumor Thrombus	Observational	Recruiting	2025-09	China
Multi-center Study on Comprehensive Diagnosis and Treatment of Lower Limb Bone Defect Based on Three-dimensional Printing Technology NCT06269354 · ClinicalTrials.gov ↗ · Bone Defects	Observational	Recruiting	2023-11	China
A Real-world Study on the Influencing Factors of Efficacy of Ruxolitinib Cream in Vitiligo NCT07153666 · ClinicalTrials.gov ↗ · Vitiligo Drug: Ruxolitinib	Observational	Recruiting	2025-12	China
Screening of Malignant Hyperthermia Susceptible Individuals NCT05402839 · ClinicalTrials.gov ↗ · Malignant Hyperthermia	Observational	Recruiting	2022-02	China
A Cohort Study of Hereditary Ovarian Cancer Risk Prediction Models and Pathogenesis Exploration NCT06564428 · ClinicalTrials.gov ↗ · Ovarian Neoplasms	Observational	Recruiting	2024-01	China
China Imaging-based Biobank of Cerebral Small Vessal Diseases NCT04962295 · ClinicalTrials.gov ↗ · Cerebral Small Vessel Diseases	Observational	Recruiting	2020-10	China
Evaluation of diagnostiC Capacity of eccDNAs as Biomarkers in Indetermined biLiary Stricture(ECCBILE) NCT06277531 · ClinicalTrials.gov ↗ · Biliary Stricture, Bile Duct Cancer, Pancreas Cancer	Observational	Recruiting	2024-03	China
Three Cancellous Screws Versus Four Cancellous Screws for Femoral Neck Fixation NCT04869332 · ClinicalTrials.gov ↗ · Femoral Neck Fractures, Internal Fixation	Not applicable	Recruiting	2021-04	China
The Impact of Preoperative Quantitative Flow Reserve (QFR) on Early Postoperative Radial Artery Graft Outcomes in Coronary Artery Bypass Grafting NCT07669987 · ClinicalTrials.gov ↗ · Quantitative Flow Reserve, Minimally Invasive Coronary Surgery, Radial Artery	Observational	Recruiting	2023-01	China
The Effect of VitC on IVF Outcome of DOR Patients NCT06794047 · ClinicalTrials.gov ↗ · Diminished Ovarian Reserve, IVF Outcomes	Not applicable	Recruiting	2025-03	China
Clinical Study on the Treatment of Pelvic Pain With Wearable Dual-band LED Device NCT06982989 · ClinicalTrials.gov ↗ · Pelvic Pain	Not applicable	Recruiting	2023-01	China
Multimodal Ocular Diagnosis-Guided Precision Acupuncture and Lifestyle Intervention for PCOS NCT07809503 · ClinicalTrials.gov ↗ · Polycystic Ovary Syndrome	Not applicable	Recruiting	2026-07	China
Prospective Cohort Study of the Risk of Recurrent Atrial Fibrillation After Radiofrequency Ablation NCT05638841 · ClinicalTrials.gov ↗ · Atrial Fibrillation	Observational	Recruiting	2023-01	China
A Study on Diagnosis and Treatment Strategies for Atlantoaxial Dislocation NCT06233539 · ClinicalTrials.gov ↗ · Atlantoaxial Dislocation, Treatment, Diagnostic	Observational	Recruiting	2022-12	China
Establishment of a Longitudinal Cohort for Newborns With Low Apgar Scores at Birth NCT06961123 · ClinicalTrials.gov ↗ · Low Apgar Scores	Observational	Recruiting	2025-03	China
IM19 CAR-T Cell Therapy in Refractory Systemic Lupus Erythematosus (SLE) NCT06513429 · ClinicalTrials.gov ↗ · Refractory Systemic Lupus Erythematosus	Not applicable	Recruiting	2024-07	China
A Cohort Study of Risk Factors and Prognosis for Frequent Acute Asthma Exacerbations Phenotype NCT06621056 · ClinicalTrials.gov ↗ · Asthma Exacerbations	Observational	Recruiting	2022-01	China
The Clinical Study of 3D-printed Magnesium Alloy Prosthesis With Controllable Degradation Rate in the Repair of Periarticular Bone Defects NCT06349629 · ClinicalTrials.gov ↗ · Degradation of Magnesium Alloy Prosthesis and New Bone Regeneration	Not applicable	Recruiting	2023-01	China
Multi-Agent Collaborative ADR Prediction With Human-Machine Decision Comparison NCT07808866 · ClinicalTrials.gov ↗ · Adverse Drug Reactions, Clinical Decision Support	Observational	Recruiting	2026-06	China
Efficacy and Safety of Photodynamic Therapy for CIN3 NCT07009327 · ClinicalTrials.gov ↗ · Precancerous Cervical Lesion	Not applicable	Recruiting	2024-01	China
The Cohort Construction Project of Peking University Third Hospital NCT07761676 · ClinicalTrials.gov ↗ · Multiple Chronic Conditions (Unspecified), Large-scale Health Examination Cohort	Observational	Recruiting	2025-02	China
NK Cell Therapy for Malignant Solid Brain Tumors NCT07552233 · ClinicalTrials.gov ↗ · Malignant Solid Brain Tumors, Glioblastoma (GBM), Glioblastoma Multiforme (GBM)	Not applicable	Recruiting	2026-04	China
Research and Clinical Validation of a Wearable Device-Based Remote Rehabilitation System for Postoperative Rotator Cuff Injury NCT07412184 · ClinicalTrials.gov ↗ · Rotator Cuff Tear	Not applicable	Recruiting	2026-01	China
Human Dental Pulp Mesenchymal Stem Cells for the Treatment of Chronic Periodontitis Patients NCT05924373 · ClinicalTrials.gov ↗ · Periodontitis	Phase 2	Recruiting	2023-11	China
68Ga-SorB PET/CT Imaging in Patients With Solid Tumors NCT07760012 · ClinicalTrials.gov ↗ · Melanoma (Skin Cancer), Hepatocellular Carcinoma, Lung Cancer	Not applicable	Recruiting	2026-07	China
Effects of a Preoperative Cognitive-Behavioral Intervention on Kinesiophobia and Function in Anterior Cruciate Ligament Reconstruction NCT07423767 · ClinicalTrials.gov ↗ · Anterior Cruciate Ligament (ACL) Tear	Not applicable	Recruiting	2026-02	China
Delineation of Target Volume of Stereotactic Radiotherapy for Spinal Tumors NCT06587022 · ClinicalTrials.gov ↗ · Spinal Tumor	Observational	Recruiting	2017-01	China
Risk Factors and Biomarkers for Post-tuberculosis Lung Damage NCT05426720 · ClinicalTrials.gov ↗ · Pulmonary TB	Observational	Recruiting	2022-01	China
Multicenter Prospective Cohort Study of Twin Maternal-Child Dyads in China NCT06414655 · ClinicalTrials.gov ↗ · Twin Pregnancy, Antepartum Condition or Complication, Twin to Twin Transfusion as Antepartum Condition, Pre-Term	Observational	Recruiting	2024-03	China
Real Time Continuous Glucose Monitoring System in T2DM With Pregnacy NCT05947916 · ClinicalTrials.gov ↗ · Type2diabetes, Pregnancy Related, Continuous Glucose Monitoring	Not applicable	Recruiting	2024-01	China
Exploratory Study on the Role of Vitamin C in Promoting Health in Middle-Aged and Elderly Adults NCT06794255 · ClinicalTrials.gov ↗ · Ageing	Not applicable	Recruiting	2025-04	China
Establishment of a Clinical and Prognostic Follow-up Cohort of Migraine Patients With Patent Foramen Ovale NCT06953622 · ClinicalTrials.gov ↗ · Migraine, Patent Foramen Ovale	Observational	Recruiting	2024-01	China
The Efficacy of Modified Olfactory Training Method for Patients With Post-viral Olfactory Dysfunction NCT06829706 · ClinicalTrials.gov ↗ · Olfactory Dysfunction, Post Viral Olfactory Dysfunction (PVOD)	Not applicable	Recruiting	2025-03	China
A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian Cancer NCT07532434 · ClinicalTrials.gov ↗ · Ovarian Cancer, Breast Cancer	Observational	Recruiting	2025-09	China
Effect of Visual-Guided Balance Training on Knee Motor Function and Biomechanical Characteristics After ACL Reconstruction NCT07306221 · ClinicalTrials.gov ↗ · Anterior Cruciate Ligament Injuries	Not applicable	Recruiting	2025-11	China
Safety and Efficacy of SBRT in the Treatment of Thoracic Malignant Tumors at Different Sites NCT05349552 · ClinicalTrials.gov ↗ · Radiotherapy, Thoracic Cancer, Safety and Efficacy	Observational	Recruiting	2022-05	China
Microfracture With Platelet Rich Plasma Gel Injection for Osteochondral Lesion of the Talus NCT06358807 · ClinicalTrials.gov ↗ · Osteochondral Lesion of Talus, Microfractures, Platelet Rich Plasma	Not applicable	Recruiting	2024-01	China
Effects of Preoperative Rehabilitation on Tendon Healing, Bone Mineral Density, and Cartilage After ACLR and Patellar Dislocation NCT05924178 · ClinicalTrials.gov ↗ · Anterior Cruciate Ligament Rupture	Not applicable	Recruiting	2023-07	China
Liraglutide Treatment in Obese Infertile PCOS Women NCT06742710 · ClinicalTrials.gov ↗ · PCOS, Obesity, Infertility Drug: Metformin	Phase 4	Recruiting	2025-05	China
Preventive Effect of Limited Decompression on Adjacent Segment Following Posterior Lumbar Interbody Fusion NCT04469387 · ClinicalTrials.gov ↗ · Degenerative Lumbar Spinal Stenosis, Degenerative Disc Disease, Degeneration Spine	Not applicable	Recruiting	2020-09	China
An Exploratory Research on the Efficacy and Safety of Antibacterial Absorbable Dressing in Chronic Non-healing Wounds NCT07261501 · ClinicalTrials.gov ↗ · Wound Heal, Wound Healing Delayed	Not applicable	Recruiting	2025-11	China
Safety and Effectiveness of No-touch Technique for Ascending Aorta in MICS-CABG NCT07172620 · ClinicalTrials.gov ↗ · Coronary Artery Bypass Grafting, Off-pump Coronary Artery Bypass, Minimally Invasive Cardiac Surgery	Observational	Recruiting	2025-06	China
A Prospective Cohort Study on Prognostic Factors in Patients With Cardiovascular-kidney-metabolic Syndrome NCT07327606 · ClinicalTrials.gov ↗ · Patient With Cardiovascular-kidney-metabolic Syndrome	Observational	Recruiting	2025-05	China
Evaluation of the Effect of SURGICEL® Powder in TKA NCT06608992 · ClinicalTrials.gov ↗ · Knee Osteoarthritis	Phase 4	Recruiting	2024-09	China
Efficacy and Safety of Brivudine in the Treatment of Herpes Zoster NCT07099157 · ClinicalTrials.gov ↗ · Herpes Zoster	Phase 4	Recruiting	2025-08	China
Trigger Timing in Ovarian Stimulations NCT04163133 · ClinicalTrials.gov ↗ · IVF Outcome	Not applicable	Recruiting	2020-04	China
Safety and Efficacy of SBRT in the Reirradiation for Ultra-central Thoracic Malignant Tumors NCT05189054 · ClinicalTrials.gov ↗ · Stereotactic Body Radiation Therapy, Irradiation; Reaction, Thoracic Tumor	Observational	Recruiting	2022-05	China
Effect of Preoperative Exercise Habits on Knee Function and Recurrence Rate After Anterior Cruciate Ligament Reconstruction NCT06608394 · ClinicalTrials.gov ↗ · Anterior Cruciate Ligament Rupture	Observational	Recruiting	2024-11	China
Allogeneic γδT Cells in Glioblastoma NCT07144735 · ClinicalTrials.gov ↗ · Glioblastoma (GBM), Glioblastoma Multiforme (GBM)	Not applicable	Recruiting	2025-04	China
Effect of Pre-existing Adjacent Segment Degeneration on Long-term Effectiveness After Lumbar Fusion Surgery NCT04467944 · ClinicalTrials.gov ↗ · Degenerative Lumbar Spinal Stenosis, Degenerative Disc Disease, Degeneration Spine	Observational	Recruiting	2018-01	China
Prospective Cohort Study on Fuzheng Yangxin Prescription For Rapid Rehabilitation of Patients With Qi-Yin Deficiency Syndrome After Coronary Artery Bypass Grafting NCT06961136 · ClinicalTrials.gov ↗ · Coronary Artery Bypass	Observational	Recruiting	2025-05	China
Value of Super-resolution Ultrasonography in Differentiating Benign and Malignant Lymph Nodes NCT07155954 · ClinicalTrials.gov ↗ · Lymphadenopathy, Lymphnode Metastasis, Lymphoma	Observational	Recruiting	2024-10	China
Clinical Study to Evaluate the Efficacy and Safety of FB1006 in the Treatment of ALS Patients NCT05923905 · ClinicalTrials.gov ↗ · Sporadic and Familial Amyotrophic Lateral Sclerosis	Phase 4	Recruiting	2023-01	China
Predicting Model Based on Evidence-based Pathological Diagnose Criteria for RCC Tumor Thrombus With IVC Wall Invasion NCT05589207 · ClinicalTrials.gov ↗ · Carcinoma, Renal Cell, Tumor Thrombus, Neoplasm Invasiveness	Observational	Recruiting	2023-01	China
The Application of Contrast-enhanced Ultrasound in Acute Kidney Injury in ICU NCT06341062 · ClinicalTrials.gov ↗ · Intensive Care Unit, Acute Kidney Injury, Ultrasound	Observational	Recruiting	2024-04	China
The Clinical Outcomes of the Modified Broström vs Anatomic Reconstruction Operation in CLAI and GJL NCT05196906 · ClinicalTrials.gov ↗ · Ankle Sprains, Instability, Joint, Joint Hypermobility	Observational	Recruiting	2020-01	China
China Gender-affirming Hormone Therapy Study NCT05318755 · ClinicalTrials.gov ↗ · Transgender, Gender Incongruence	Observational	Recruiting	2022-04	China
Effect of Early Gait Training on Knee Cartilage Degeneration After Anterior Cruciate Ligament Reconstruction NCT06368544 · ClinicalTrials.gov ↗ · Anterior Cruciate Ligament Injuries, Cartilage Degeneration	Not applicable	Recruiting	2024-07	China
Assessing the Performance of GPT-4o in Evaluating the Safety of Home Environment for Older Adults NCT06962696 · ClinicalTrials.gov ↗ · Elderly (People Aged 65 or More), Home Environment Related Disease	Observational	Recruiting	2025-03	China
The Effeciency of NMN in Improving IVF/ICSI-ET Pregnancy Outcomes in Patients With DOR NCT06426355 · ClinicalTrials.gov ↗ · Diminished Ovarian Reserve	Not applicable	Recruiting	2023-10	China
Sitagliptin or BeiDouGen Capsule Improve the Pregnancy Outcome in Patients with PCOS NCT06587698 · ClinicalTrials.gov ↗ · Polycystic Ovarian Syndrome Drug: Sitagliptin	Not applicable	Recruiting	2024-08	China
Natural History and Clinical Features of Amyotrophic Lateral Sclerosis (ALS) NCT04454892 · ClinicalTrials.gov ↗ · Amyotrophic Lateral Sclerosis	Observational	Recruiting	2019-11	China
Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy in Prostate Cancer Patients With Lymph Node-positive After Radical Prostatectomy: A Prospective Observational Cohort Study NCT06435702 · ClinicalTrials.gov ↗ · Prostate Cancer	Observational	Not yet open	2024-06	China
Impact of Structural and Microenvironmental Abnormalities in Olfactory Cleft on Olfaction in CRS NCT06834477 · ClinicalTrials.gov ↗ · Chronic Rhinosinusitis (CRS)	Observational	Not yet open	2025-03	China
Zishen Yutai Pill for Patients With Recurrent Implantation Failure NCT07641088 · ClinicalTrials.gov ↗ · Recurrent Implantation Failure	Not applicable	Not yet open	2026-07	China
A Prospective Multicenter Clinical Study on the Efficacy and Safety of the Zirconia Ceramic Hip Joint Prosthesis System After Its Market Launch NCT07382050 · ClinicalTrials.gov ↗ · THA, Prosthesis	Observational	Not yet open	2026-01	China
Effects of GLP-1RAs on Fertility Outcomes in Obese Women With PCOS NCT07687667 · ClinicalTrials.gov ↗ · Polycystic Ovary Syndrome (PCOS), Obesity, Infertility, Female Drug: Metformin	Not applicable	Not yet open	2026-07	China
The ctDNA for Evaluating Whether to Use Adjuvant Therapy After SBRT in Patients With Early Lung Cancer NCT05411809 · ClinicalTrials.gov ↗ · Stereotactic Body Radiation Therapy	Not applicable	Not yet open	2022-06	China
The Efficacy of Modified Olfactory Training for MCI High-Risk Individuals NCT06821828 · ClinicalTrials.gov ↗ · Subjective Cognitive Decline (SCD), Olfactory Dysfunction, Mild Cognitive Impairment (MCI)	Not applicable	Not yet open	2025-03	China
A Smart Wearable Device for Monitoring Urination Function in Benign Prostatic Hyperplasia NCT07357012 · ClinicalTrials.gov ↗ · Benign Prostatic Hyperplasia	Observational	Not yet open	2026-01	China
Allogeneic vs Autologous PRP for Diabetic Wounds in Renal Dysfunction: a Randomized Controlled Trial NCT07020559 · ClinicalTrials.gov ↗ · Diabetic Wounds, Platelet Rich Plasma, Allogeneic Blood Transfusions	Phase 4	Not yet open	2026-04	China
A Randomized Controlled Trial: Fuzheng Yangxin Formula for ERAS After CABG NCT07781436 · ClinicalTrials.gov ↗ · CAD - Coronary Artery Disease, CABG, ERAS	Not applicable	Not yet open	2026-08	China
Conservative Treatment for Atlantoaxial Dislocation Patients Without Neurological Deficit NCT06772311 · ClinicalTrials.gov ↗ · Atlantoaxial Dislocation	Observational	Not yet open	2025-01	China
Endoscopic Submucosal Dissection Versus Surgery in the Treatment of Early Gastric Cancer NCT03857737 · ClinicalTrials.gov ↗ · Early Gastric Cancer	Not applicable	Not yet open	2019-03	China
Intraperitoneal Lidocaine in Ovarian Cancer Surgery NCT05450055 · ClinicalTrials.gov ↗ · Ovarian Cancer, Post Operative Pain	Not applicable	Not yet open	2022-07	China
Sustentaculum Tali Screw Fixation Mode and Postoperative Foot-Ankle Function in Calcaneal Fractures NCT07822698 · ClinicalTrials.gov ↗ · Calcaneal Fractures	Observational	Not yet open	2026-09	China

Showing the 100 most recently updated of 159 trials (recruiting first). The rest are in the country registers linked in each row.

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

Drugs in Peking University Third Hospital trials

17 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

Metformin3 Cisplatin1 Enfortumab Vedotin1 Gemcitabine1 Glofitamab1 Infliximab1 Lenalidomide1 Levofloxacin1 Lorlatinib1 Nimotuzumab1 Orelabrutinib1 Pomalidomide1 Ruxolitinib1 SNUG011 Sitagliptin1 Toripalimab1 Zuberitamab1

Conditions in Peking University Third Hospital trials

252 conditions

Olfactory Dysfunction4Obesity3Anterior Cruciate Ligament Injuries3Degeneration Spine3Atlantoaxial Dislocation3Anterior Cruciate Ligament Rupture3Polycystic Ovary Syndrome3Chronic Rhinosinusitis (CRS)2Infertility, Female2Ankle Sprains2Thyroid Eye Disease2Stereotactic Body Radiation Therapy2Precancerous Cervical Lesion2Wound Heal2Platelet Rich Plasma2Ovarian Cancer2Tumor Thrombus2Cerebral Small Vessel Diseases2 Amyotrophic Lateral Sclerosis2Diminished Ovarian Reserve2Radiotherapy2 Glioblastoma (GBM)2Glioblastoma Multiforme (GBM)2Breast Cancer2

By trial register

Register	Trials	Recruiting
Clinical trials in China	159	86

A trial with sites in more than one country appears in each of those registers; recruiting counts cover the trials listed on this page.

Questions about Peking University Third Hospital trials

How many clinical trials does Peking University Third Hospital sponsor?

Peking University Third Hospital is the lead sponsor of 159 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 27 September 2026. Completed and withdrawn studies are not counted.

Are Peking University Third Hospital trials recruiting?

Yes. 86 of its 159 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Peking University Third Hospital testing?

Its current trials name 17 drugs and biologicals as interventions. The most frequent are Metformin (3), Cisplatin (1), Enfortumab Vedotin (1), Gemcitabine (1) and Glofitamab (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 27 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.

Peking University Third Hospital clinical trials